User: Guest  Login
Sort by:
and:

Schoop, R;Wahl, P;Le Hir, M;Heemann, U;Wang, M;Wüthrich, RP
Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells.
Nephrol Dial Transplant
2004
19
11
2713-20

Neuhofer, W;Holzapfel, K;Fraek, ML;Ouyang, N;Lutz, J;Beck, FX
Chronic COX-2 inhibition reduces medullary HSP70 expression and induces papillary apoptosis in dehydrated rats.
Kidney Int
2004
65
2
431-41

Michel, MC;Heemann, U;Schumacher, H;Mehlburger, L;Goepel, M
Association of hypertension with symptoms of benign prostatic hyperplasia.
J Urol
2004
172
4 Pt 1
1390-3

Wang, M;Liu, S;Ouyang, N;Song, E;Lutz, J;Heemann, U
Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
Kidney Int
2004
66
3
1248-56

Viklický, O;Bohmová, R;Ouyang, N;Honsová, E;Lodererová, A;Mandys, V;Vítko, S;Lutz, J;Heemann, UW
Effect of sirolimus on renal ischaemia/reperfusion injury in normotensive and hypertensive rats.
Transpl Int
2004
17
8
432-41

Philipp, S;Pagel, I;Höhnel, K;Lutz, J;Buttgereit, J;Langenickel, T;Hamet, P;Dietz, R;Willenbrock, R
Regulation of caspase 3 and Fas in pressure overload-induced left ventricular dysfunction.
Eur J Heart Fail
2004
6
7
845-51

Michel, MC;Bohner, H;Koster, J;Schäfers, R;Heemann, U
Safety of telmisartan in patients with arterial hypertension : an open-label observational study.
Drug Saf
2004
27
5
335-44

Frank, H;Heusser, K;Höffken, B;Huber, P;Schmieder, RE;Schobel, HP
Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
Kidney Int
2004
66
2
832-40

Fischer, T;Schobel, HP;Frank, H;Andreae, M;Schneider, KT;Heusser, K
Pregnancy-induced sympathetic overactivity: a precursor of preeclampsia.
Eur J Clin Invest
2004
34
6
443-8

Hausleiter, J;Kastrati, A;Mehilli, J;Vogeser, M;Zohlnhofer, D;Schuhlen, H;Goos, C;Pache, J;Dotzer, F;Pogatsa-Murray, G;Dirschinger, J;Heemann, U;Schömig, A
Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial.
Circulation
2004
110
7
790-5